Medtronic Aktie

81,59USD 0,19USD 0,23%
Medtronic für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A14M2J / ISIN: IE00BTN1Y115
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,93
The Vanguard Group, Inc. 9,87
Vanguard Group, Inc. (Subfiler) 9,16
State Street Corp. 4,74
Vanguard Total Stock Market ETF 3,16
BlackRock Fund Advisors 2,87
Vanguard 500 Index Fund 2,65
Capital Research & Management Co. (Global Investors) 2,54
BlackRock Institutional Trust Co. NA 2,31
Geode Capital Management LLC 2,07
Massachusetts Financial Services Co. 1,90
JPMorgan Investment Management, Inc. 1,65
Wellington Management Co. LLP (Wellington Breakout) 1,37
SPDR S&P 500 ETF Trust 1,23
Fidelity 500 Index Fund 1,23

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 90 000 90 000 95 000 95 000 95 000
Umsatz pro Mitarbeiter in Mio. EUR 0,32 0,33 0,33 0,33 0,34

Bilanz (in Mio. USD) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 22 031 22 548 23 059 21 675 21 935
Summe Anlagevermögen 68 658 70 535 67 922 69 273 68 046
Summe Aktiva 90 689 93 083 90 981 90 948 89 981

Bilanz (in Mio. USD) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 39 817 41 481 38 260 39 283 39 561
Summe Eigenkapital 50 872 51 602 52 722 51 665 50 420
Summe Passiva 90 689 93 083 90 982 90 948 89 981

Adresse

Parkmore Business Park West, 2 Galway
Telefon +353 (1) 438-1700
Internet http://www.medtronic.com

Management

Alexandra Clyde
SVP-Global Health Economics & Policy
Andrea J. Goldsmith
Independent Director
Bob Hopkins
Senior Vice President & Head-Global Strategy
Craig Arnold
Lead Independent Director
Elizabeth G. Nabel
Independent Director
Gary Corona
CFO, SVP-Global Financial Planning & Analysis
Geoffrey Straub Martha
Chairman & Chief Executive Officer
Gregory L. Smith
Executive VP-Global Operations & Supply Chain
Gregory P. Lewis
Independent Director
Harry Skip Kiil
President-Cranial & Spinal Technologies
Ivan K. Fong
Secretary, Executive VP & General Counsel
Jennifer M. Kirk
Chief Accounting Officer, SVP & Global Controller
Kelly Wei
Vice President-Corporate Strategy
Kendall J. Powell
Independent Director
Kenneth E. Washington
SVP, Director-Technology & Innovation
Kevin E. Lofton
Independent Director
Laura Mauri
Director-Scientific, Clinical & Regulatory Officer
Lidia L. Fonseca
Independent Director
Matthew Walter
Chief Human Resources Officer
Mira Sahney
President-Pelvic Health Operating Unit
Que Thanh Dallara
EVP & President-Global Diabetes Operating Unit
Raman Venkatesh
Chief Sustainability Officer & Vice President
Randall J. Hogan
Independent Director
Ryan Weispfenning
Vice President & Head-Investor Relations
Sally Saba
Chief Inclusion & Diversity Officer
Scott C. Donnelly
Independent Director
Scott Cundy
Chief Quality Officer & Senior Vice President
Sean Salmon
EVP, President-Cardiovascular Portfolio